LAUSR

Efficacy and safety of subcutaneous versus intravenous bortezomib in multiple myeloma: a meta-analysis
.

Sign Up to like & get
recommendations!
0 Published in 2017 at "International journal of clinical pharmacology and therapeutics"

DOI: 10.5414/cp202714

Abstract: PURPOSE We performed this meta-analysis to compare the efficacy and safety between two different administration routes of bortezomib, subcutaneous and intravenous. METHODS Six retrospective studies and three randomized controlled trials (RCTs) were included in our… read more here.

Keywords: efficacy safety; intravenous bortezomib; bortezomib; retrospective studies ... See more keywords